Gregory Ekizian serves as Executive at Protagenic Therapeutics, Inc. ew, where they oversee executive responsibilities. Since joining the company, Gregory Ekizian has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 17, 2016 involved receiving (via award) 45,000 shares valued at $56.3K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 17, 2016 | ATRN | $56.3K | Award | 45,000 | $1.25 | Discretionary |
Gregory Ekizian currently holds 645,000 shares of Protagenic Therapeutics, Inc. ew (ATRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Ekizian has been a net neutral trader of ATRN stock. They have purchased $0 and sold $0 worth of shares.
Gregory Ekizian's most recent insider trade was on Jun 17, 2016, when they sold 45,000 shares at $1.25 per share.
Get notified when new Form 4 filings are submitted